Congenital Central Hypoventilation Syndrome (CCHS) is a rare, life-threatening genetic disorder of the autonomic nervous system characterized by alveolar hypoventilation and generalized dysautonomia. CCHS is caused by heterozygous PHOX2B mutations, predominantly polyalanine repeat expansion (95% of cases) and, less frequently, frameshift mutations (5%). To address the lack of disease models, we generated five human induced pluripotent stem cell (hiPSC) lines derived from patients carrying +5Ala, +6Ala and +11Ala expansion mutations. These hiPSC lines exhibited undifferentiated hPSC phenotype, pluripotency, normal karyotype, and retention of the pathogenic genotype, providing a reliable in vitro platform for elucidating CCHS molecular mechanisms and disease pathogenesis.

Generation of iPSC lines (UMILi032-A, UMILi033-A, UMILi034-A, UMILi035-A, UMILi036-A) from five Congenital Central Hypoventilation Syndrome patients carrying different poly-alanine expansion mutations in the PHOX2B gene / A.L. Cuadros Gamboa, F. Chiesa, P. Pelucchi, M. Bertocchi, A. Ripepi, E. Piscitelli, M. Peruzzi, N. Nassi, C. Arzilli, M. Annunziata, A. Morrone, V. Tritto, P. Riva, G. Santamaria, I. Ceccherini, R. Benfante, S. Di Lascio, D. Fornasari. - In: STEM CELL RESEARCH. - ISSN 1873-5061. - 90:(2026 Feb), pp. 103888.1-103888.6. [10.1016/j.scr.2025.103888]

Generation of iPSC lines (UMILi032-A, UMILi033-A, UMILi034-A, UMILi035-A, UMILi036-A) from five Congenital Central Hypoventilation Syndrome patients carrying different poly-alanine expansion mutations in the PHOX2B gene

A.L. Cuadros Gamboa
Co-primo
;
F. Chiesa
Co-primo
;
P. Pelucchi;M. Bertocchi;E. Piscitelli;V. Tritto;P. Riva;R. Benfante;S. Di Lascio
;
D. Fornasari
2026

Abstract

Congenital Central Hypoventilation Syndrome (CCHS) is a rare, life-threatening genetic disorder of the autonomic nervous system characterized by alveolar hypoventilation and generalized dysautonomia. CCHS is caused by heterozygous PHOX2B mutations, predominantly polyalanine repeat expansion (95% of cases) and, less frequently, frameshift mutations (5%). To address the lack of disease models, we generated five human induced pluripotent stem cell (hiPSC) lines derived from patients carrying +5Ala, +6Ala and +11Ala expansion mutations. These hiPSC lines exhibited undifferentiated hPSC phenotype, pluripotency, normal karyotype, and retention of the pathogenic genotype, providing a reliable in vitro platform for elucidating CCHS molecular mechanisms and disease pathogenesis.
Settore BIOS-11/A - Farmacologia
Settore BIOS-10/A - Biologia cellulare e applicata
   Assegnazione Dipartimenti di Eccellenza 2023-2027 - Dipartimento di BIOTECNOLOGIE MEDICHE E MEDICINA TRASLAZIONALE
   DECC23_003
   MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
feb-2026
15-dic-2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1873506125002387-main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 3.97 MB
Formato Adobe PDF
3.97 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1206096
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex 0
social impact